SCHEMBL8613449

SCHEMBL8613449

CC(C)(O)CNc1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HTT P42858 3/20 0.42
MEN1 O00255 3/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
XBP1 P17861 1/20 0.42
MAPK1 P28482 1/20 0.42
GAA P10253 2/20 0.40
LMNA P02545 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
HPGD P15428 1/20 0.40
FPR2 P25090 1/20 0.39
SCN9A Q15858 1/20 0.39
ABCC9 O60706 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12932913 0.83 ALDH1A1 (0.40) KMT2ASMN1; SMN2HTTMEN1CYP3A4
SCHEMBL10126871 0.81 MAPT (0.54) KMT2AHTTMEN1MAPTRAB9A
SCHEMBL6701038 0.79 KIT (0.38) KMT2ASMN1; SMN2HTTMEN1CYP3A4
SCHEMBL2015299 0.78 MAPT (0.44) KMT2AMEN1CYP3A4CYP2C9CYP2C19
SCHEMBL6697703 0.76 ALDH1A1 (0.40) KMT2ASMN1; SMN2HTTMEN1CYP3A4
SCHEMBL6701656 0.76 ALDH1A1 (0.40) KMT2ASMN1; SMN2HTTMEN1CYP3A4
SCHEMBL11556501 0.76 AR (0.39) KMT2ASMN1; SMN2HTTMEN1MAPT
SCHEMBL14255794 0.75 EGLN2 (0.52) SMN1; SMN2HTTSCN9AABCC9KCNJ11
SCHEMBL25374366 0.74 IDH2 (0.36) KMT2AMEN1MAPTFPR2SCN9A
SCHEMBL31368961 0.74 MAPT (0.47) KMT2AHTTMEN1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5837702-A HAVING POTASSIUM CHANNEL ACTIVATING ACTIVITY USEFUL AS CARDIOVASCULAR AGENTS AND TREATMENT OF ISCHEMIA BRISTOL-MYERS SQUIBB CO. (US) 1998-11-17 US disclosed
EP-0648758-A1 4-Arylamino-benzopyran and related compounds BRISTOL-MYERS SQUIBB COMPANY (US) 1995-04-19 EP disclosed